Verrica Pharmaceuticals Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2018-02-21: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-02-20; Total offering amount $21,000,000.
- 2017-12-22: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-12-15; Total offering amount $5,000,000.
- 2015-12-17: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-12-02; Total offering amount Indefinite.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2018-02-21 | Rule 506(b) | Equity | 2018-02-20 | $21,000,000 | $19,999,995 | $1,000,005 | 2 |
|---|
| 2017-12-22 | Rule 506(b) | Equity | 2017-12-15 | $5,000,000 | $5,000,000 | $0 | 1 |
|---|
| 2015-12-17 | Rule 506(b) | Equity | 2015-12-02 | Indefinite | $2,434,186 | Indefinite | 14 |
|---|